Award recordCONTRACT

BAYER HEALTHCARE PHARMACEUTICALS INC

PIID VA24717F0673· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· Q527 · MEDICAL- NUCLEAR MEDICINE· FY2017· $213,438 net obligations· UEI V1EVGCK7XES8· NJ

Description

IGF:CL:IGF XOFIGO (RADIUM RA 223 DICHLORIDE)

Base award description: IGF::CL::IGF XOFIGO (RADIUM RA 223 DICHLORIDE)

First action · last action
2017-01-11 · 2019-07-19
Transactions
2
First transaction's obligation
$244,439
Base + all options value (sum of deltas)
$213,439
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2202D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$244,439$0Base award · 2017-01-11 · this action $244,439 · running total $244,439Modification P00001 · 2019-07-19 · this action -$31,001 · running total $213,438
  • Base2017-01-11+$244,439= $244,439
  • Mod P000012019-07-19-$31,001= $213,438
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-01-11+$244,439$244,439IGF::CL::IGF XOFIGO (RADIUM RA 223 DICHLORIDE)
Mod P00001· CHANGE ORDER2019-07-19−$31,001$213,438IGF:CL:IGF XOFIGO (RADIUM RA 223 DICHLORIDE)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V1EVGCK7XES8)

AwardOffice · PSC / listingNet obligationsFY
36C25626N0492256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$386,860FY2026
36C26226F0163262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$181,386FY2026
36C26026F0086260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$80,663FY2026
36C26126N0199261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$101,567FY2026
36C25626N0126256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$214,783FY2026
36E79725A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under Q527 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0726PETNET SOLUTIONS, INC.247-NETWORK CONTRACT OFFICE 7 (36C247)$1,575,677FY2026
36C24726P0672JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.247-NETWORK CONTRACT OFFICE 7 (36C247)$112,908FY2026
36C24726P0659TRILLAMED LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$261,598FY2026
36C24726C0041PETNET SOLUTIONS, INC.247-NETWORK CONTRACT OFFICE 7 (36C247)$288,295FY2026
36C24725P1135CARDINAL HEALTH 414, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$167,038FY2025

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24717F0673_3600_V797P2202D_3600 · retrieved 2026-09-26.